20 results on '"Susan M. Bueno"'
Search Results
2. Sinovac Biotech Co. Ltd. Researchers Publish New Studies and Findings in the Area of Influenza Vaccines (Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3,...).
3. Sinovac Biotech Co. Ltd. Researchers Publish New Studies and Findings in the Area of Influenza Vaccines (Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, ...)
4. Reports from Aristotle University of Thessaloniki Add New Data to Research in Respiratory Syncytial Viruses (Respiratory Syncytial Virus Vaccines: Analysis of Pre-Marketing Clinical Trials for Immunogenicity in the Population over 50 Years of ...)
5. Researchers at Pontificia Universidad Catolica de Chile Release New Study Findings on COVID-19 [Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac[superscript]®) According to Age Group in a Pediatric Population from 3 to 17 Years
6. Report Summarizes COVID-19 Study Findings from Millennium Institute on Immunology and Immunotherapy (Differential Severe Acute Respiratory Syndrome Coronavirus 2-specific Humoral Response In Inactivated Virus-vaccinated, Convalescent, and ...)
7. Research from Pontificia Universidad Catolica de Chile in the Area of COVID-19 Published (Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A ...)
8. Studies from Millennium Institute on Immunology and Immunotherapy Reveal New Findings on COVID-19 (Humoral and Cellular Response Induced By a Second Booster of an Inactivated Sars-cov-2 Vaccine In Adults)
9. Research from Millennium Institute on Immunology and Immunotherapy Has Provided New Study Findings on Streptococcus pneumoniae (Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection)
10. Researchers at Pontificia Universidad Catolica de Chile Publish New Data on COVID-19 (Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial)
11. Study Findings from Pontificia Universidad Catolica de Chile Update Knowledge in COVID-19 (BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and * * Andes orthohantavirus* *)
12. Researchers from Millennium Institute on Immunology and Immunotherapy Detail Findings in COVID-19 (Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine In a Subgroup of Healthy Adults In Chile)
13. Research Results from Millennium Institute on Immunology and Immunotherapy Update Understanding of COVID-19 (Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine)
14. Researchers from Pontifical Catholic University of Chile Provide Details of New Studies and Findings in the Area of Metapneumovirus (Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the ...)
15. Data from Pontifical Catholic University of Chile Broaden Understanding of Respiratory Syncytial Viruses (Induction of Trained Immunity by Recombinant Vaccines)
16. New Bacillus Calmette-Guerin Vaccines Research from Pontifical Catholic University of Chile Discussed (Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, ...)
17. Reports from Pontifical Catholic University of Chile Advance Knowledge in Respiratory Syncytial Viruses (Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections)
18. New Study Findings from Pontifical Catholic University of Chile Illuminate Research in COVID-19 (Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?)
19. New Findings from Pontifical Catholic University in the Area of Bacillus Calmette-Guerin Vaccines Described (BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design)
20. Studies from Pontifical Catholic University Reveal New Findings on Respiratory Syncytial Viruses (Contribution of Resident Memory CD8[superscript]+ T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.